Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06538298 · ClinicalTrials.gov registry record · Early Phase 1

Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)

A Early Phase 1 study of Parkinson Disease, sponsored by California State University, Northridge.

Recruiting
Registry status
Early Phase 1
Development phase
50
Enrollment target
1
Study location

NCT06538298 is a Early Phase 1 study of Parkinson Disease that is actively recruiting participants, run by California State University, Northridge. The registered enrollment target is 50 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06538298, a Early Phase 1 study of Parkinson Disease, is actively recruiting participants, sponsored by California State University, Northridge.

RECRUITING
Registry status
Early Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals with Parkinson Disease.

Conditions Studied

Interventions

  • OTHER Multimodal Exercise Program with Gamification

Study Locations (1)

California

  • Equilibrium Physical Therapy - Ventura

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-15
Est. Completion 2026-06-27
Phase Early Phase 1

What the Registry Record Tells You About NCT06538298

The ClinicalTrials.gov registry entry for NCT06538298 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is California State University, Northridge, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Multimodal Exercise Program with Gamification is the first listed.

NCT06538298 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06538298 about?

NCT06538298 is a clinical study titled "Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)". In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals...

What is the current status of trial NCT06538298?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2024-09-15. Estimated completion is 2026-06-27.

What conditions does trial NCT06538298 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06538298?

The interventions under investigation include: Multimodal Exercise Program with Gamification (OTHER).

Who is sponsoring clinical trial NCT06538298?

This trial is sponsored by California State University, Northridge, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06538298 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.